⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 2, 2025Open Access

Figure S4 from Harnessing Notch Signaling to Enhance the Generation and Functionality of Human Conventional Type 1 Dendritic Cells for Cancer Immunotherapy Applications

Sreekumar Balan Liam O’Brien Ante Peros Xuedi Wang Ingrid Leal Rojas Christopher B. McClain Kristen J. Radford Nina Bhardwaj

View Full Paper

Ask AI

Bookmark

Share

Key Points

The study demonstrates enhanced functionality in cDC1s when leveraging notch signaling pathways.
Analysis showed significant differences in up- and down-regulated pathways between culture methods.
Using varying culture techniques for cDC1 generation yields essential insights for cancer immunotherapy.
These findings may enable the development of improved dendritic cell therapies targeting cancer.

Implication

This analysis reveals enriched pathways in cDC1s derived from varying culture methods, suggesting potential for cancer immunotherapy applications.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Balan et al. (2025) studied this question.

synapsesocial.com/papers/68bb4e016d6d5674bcd028b1 https://doi.org/10.1158/2326-6066.30028879

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S5 from Harnessing Notch Signaling to Enhance the Generation and Functionality of Human Conventional Type 1 Dendritic Cells for Cancer Immunotherapy Applications2025
2Figure S3 from Harnessing Notch Signaling to Enhance the Generation and Functionality of Human Conventional Type 1 Dendritic Cells for Cancer Immunotherapy Applications2025
3Figure S2 from Harnessing Notch Signaling to Enhance the Generation and Functionality of Human Conventional Type 1 Dendritic Cells for Cancer Immunotherapy Applications2025
4Figure S1 from Harnessing Notch Signaling to Enhance the Generation and Functionality of Human Conventional Type 1 Dendritic Cells for Cancer Immunotherapy Applications2025
5Figure S6 from Harnessing Notch Signaling to Enhance the Generation and Functionality of Human Conventional Type 1 Dendritic Cells for Cancer Immunotherapy Applications2025

Leveraging cDC1 biology and function for enhanced immunotherapy2026
Abstract 4914: Defining the immunoregulatory molecular drivers of dendritic cells using CRISPR screens in ex-vivo modelsvivo models2026
Supplementary Figure S2 from Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells2025